Contents
Academic literature on the topic 'Acid Oligogalacturonique'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Acid Oligogalacturonique.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Acid Oligogalacturonique"
Cook, B. J., R. P. Clay, C. W. Bergmann, P. Albersheim, and A. G. Darvill. "Fungal Polygalacturonases Exhibit Different Substrate Degradation Patterns and Differ in Their Susceptibilities to Polygalacturonase-Inhibiting Proteins." Molecular Plant-Microbe Interactions® 12, no. 8 (August 1999): 703–11. http://dx.doi.org/10.1094/mpmi.1999.12.8.703.
Full textWILLIAMS, Martin A. K., and Jacques A. E. BENEN. "A novel enzyme activity involving the demethylation of specific partially methylated oligogalacturonides." Biochemical Journal 367, no. 2 (October 15, 2002): 511–15. http://dx.doi.org/10.1042/bj20020796.
Full textZhu, Ru-Gang, Yan-Di Sun, Yu-Ting Hou, Jun-Gang Fan, Gang Chen, and Tuo-Ping Li. "Pectin penta-oligogalacturonide reduces cholesterol accumulation by promoting bile acid biosynthesis and excretion in high-cholesterol-fed mice." Chemico-Biological Interactions 272 (June 2017): 153–59. http://dx.doi.org/10.1016/j.cbi.2017.05.018.
Full textMata, Georgina Hernández, Baldemar Sepúlveda, Alan Richards, and Eva Soriano. "The architecture of Phaseolus vulgaris root is altered when a defense response is elicited by an oligogalacturonide." Brazilian Journal of Plant Physiology 18, no. 2 (June 2006): 351–55. http://dx.doi.org/10.1590/s1677-04202006000200012.
Full textZhu, Rugang, Yuting Hou, Yandi Sun, Tuoping Li, Jungang Fan, Gang Chen, and Junxiu Wei. "Pectin Penta-Oligogalacturonide Suppresses Intestinal Bile Acids Absorption and Downregulates the FXR-FGF15 Axis in High-Cholesterol Fed Mice." Lipids 52, no. 6 (May 4, 2017): 489–98. http://dx.doi.org/10.1007/s11745-017-4258-x.
Full textNorman, Cecilia, Sabina Vidal, and E. Tapio Palva. "Oligogalacturonide-Mediated Induction of a Gene Involved in Jasmonic Acid Synthesis in Response to the Cell-Wall-Degrading Enzymes of the Plant Pathogen Erwinia carotovora." Molecular Plant-Microbe Interactions® 12, no. 7 (July 1999): 640–44. http://dx.doi.org/10.1094/mpmi.1999.12.7.640.
Full textKeggi, Christian, and Joy Doran-Peterson. "The Homogalacturonan Deconstruction System of Paenibacillus amylolyticus 27C64 Requires No Extracellular Pectin Methylesterase and Has Significant Industrial Potential." Applied and Environmental Microbiology 86, no. 12 (April 17, 2020). http://dx.doi.org/10.1128/aem.02275-19.
Full textDissertations / Theses on the topic "Acid Oligogalacturonique"
Mansour, Ali. "Mécanismes physiopathologiques de la calcification vasculaire : les vésicules extracellulaires comme cible thérapeutique potentielle." Thesis, Amiens, 2020. http://www.theses.fr/2020AMIE0029.
Full textCardiovascular diseases (CVDs) are classified on top of the list among different death leading causes in the world. Calcification of the vessel wall leads to various critical cardiovascular consequences and accounts for high mortality rates in patients with many diseases like diabetes, atherosclerosis and chronic kidney disease (CKD). VC is an active process with features of bone physiology and it is regulated by multifactorial inductive and inhibitory processes. During the calcification process, Vascular Smooth Muscle Cells (VSMCs) undergo active osteogenic process to become osteoblast-like cells and release heterogeneous populations of Extracellular Vesicles (EVs). EVs act as nucleating foci for crystallization through their interaction with type 1 collagen (Col1) via integrins and their procalcifying protein content strongly supports calcification progression. Because these two mechanisms are crucial for the development of VC, they eventually represent two therapeutic targets for VC regression. Our primary objective was to identify new natural or chemically synthesized molecules that can inhibit VC. We demonstrated the ability of a specific oligogalacturonic acid (DP8), extracted from flax seeds, to inhibit in vitro and ex-vivo Pi-induced calcification by diminishing osteogenic markers expression, masking a consensus amino acid repeat found in Col1 (sequence: GFOGER), and thus preventing EVs from binding. Also we chemically synthesized a GFOGER peptide and checked its ability to inhibit calcification. Similar to DP8, GFOGER peptide was able to inhibit in vitro and ex-vivo Pi-induced calcification by downregulating osteogenic markers expression and through modifying the protein content of VSMCs derived EVs. Therefore, our work suggests two novel therapeutic approaches for the prevention of VC